TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Abbvie AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
41,763
|
31,209
|
17,942 |
Financial expenses |
235
|
101
|
25 |
Earnings before taxes |
3,032
|
2,386
|
1,263 |
Total assets |
21,763
|
21,835
|
13,836 |
Current assets |
21,474
|
21,524
|
13,498 |
Current liabilities |
10,027
|
11,765
|
6,913 |
Equity capital |
11,736
|
10,070
|
6,923 |
- share capital |
44
|
47
|
50 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
53.9%
|
46.1%
|
50.0% |
Turnover per employee | |||
Profit as a percentage of turnover |
7.3%
|
7.6%
|
7.0% |
Return on assets (ROA) |
15.0%
|
11.4%
|
9.3% |
Current ratio |
214.2%
|
182.9%
|
195.3% |
Return on equity (ROE) |
25.8%
|
23.7%
|
18.2% |
Change turnover |
12,536
|
14,210
|
1,667 |
Change turnover % |
43%
|
84%
|
10% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.